comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-14 21:59:35 - browse：53663

John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT — John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Feed a cold, starve a fever? Here’s what science says

explore

WSS

How CRISPR works, explained in two minutes

Pennsylvania man bitten on the head by bear during attack in his garage

FDA needs staff influx to meet gene therapy needs, Marks says

Many breast cancer patients receive more radiation than needed

SCOTUS to consider access to abortion pill mifepristone

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

entertainment

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

After sickle

Dobbs anniversary: the lost opportunity of abortion as health care

CMS should re

Duchenne breakthrough therapy leaves behind pioneering families

How CRISPR works, explained in two minutes

Trump demands the U.S. pay no more for drugs than other countries … again

CMS should re

BioMarin wins approval for gene therapy to treat hemophilia A

Congenital heart disease patients face new threat of heart failure

focus

Feed a cold, starve a fever? Here’s what science says

FDA needs staff influx to meet gene therapy needs, Marks says

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

With heat waves through August, officials warn of health risks

Sage considers ways to reduce costs following FDA rejection

hotspot

focus

knowledge

focus